MA26736A1 - Precurseurs medicamenteux mutuels d'amlodipine et d'atorvastatine, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Precurseurs medicamenteux mutuels d'amlodipine et d'atorvastatine, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
MA26736A1
MA26736A1 MA25986A MA25986A MA26736A1 MA 26736 A1 MA26736 A1 MA 26736A1 MA 25986 A MA25986 A MA 25986A MA 25986 A MA25986 A MA 25986A MA 26736 A1 MA26736 A1 MA 26736A1
Authority
MA
Morocco
Prior art keywords
amlodipine
atorvastatin
mutual
preparation
pharmaceutical compositions
Prior art date
Application number
MA25986A
Other languages
English (en)
Inventor
Chang George
Seiichi Hamanaka Ernest
Lawrence Lamattina John
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA26736A1 publication Critical patent/MA26736A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
MA25986A 1999-05-27 2000-05-24 Precurseurs medicamenteux mutuels d'amlodipine et d'atorvastatine, procede pour leur preparation et compositions pharmaceutiques les contenant MA26736A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13660899P 1999-05-27 1999-05-27

Publications (1)

Publication Number Publication Date
MA26736A1 true MA26736A1 (fr) 2004-12-20

Family

ID=22473579

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25986A MA26736A1 (fr) 1999-05-27 2000-05-24 Precurseurs medicamenteux mutuels d'amlodipine et d'atorvastatine, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (41)

Country Link
US (1) US6486182B1 (fr)
EP (1) EP1180102B9 (fr)
JP (1) JP2003500487A (fr)
KR (1) KR20020012247A (fr)
CN (1) CN1352640A (fr)
AP (1) AP2001002345A0 (fr)
AR (1) AR022344A1 (fr)
AT (1) ATE268764T1 (fr)
AU (1) AU3313900A (fr)
BG (1) BG106149A (fr)
BR (1) BR0011006A (fr)
CA (1) CA2375372C (fr)
CO (1) CO5170457A1 (fr)
CZ (1) CZ20014229A3 (fr)
DE (1) DE60011424T2 (fr)
DK (1) DK1180102T3 (fr)
DZ (1) DZ3048A1 (fr)
EA (1) EA200101130A1 (fr)
EE (1) EE200100631A (fr)
ES (1) ES2220426T3 (fr)
GT (1) GT200000078A (fr)
HK (1) HK1046282A1 (fr)
HN (1) HN2000000075A (fr)
HR (1) HRP20010856A2 (fr)
HU (1) HUP0201433A2 (fr)
IL (1) IL145947A0 (fr)
IS (1) IS6135A (fr)
MA (1) MA26736A1 (fr)
MX (1) MXPA01012125A (fr)
NO (1) NO20015756L (fr)
OA (1) OA11950A (fr)
PA (1) PA8495701A1 (fr)
PE (1) PE20010169A1 (fr)
PL (1) PL353483A1 (fr)
PT (1) PT1180102E (fr)
SK (1) SK16792001A3 (fr)
SV (1) SV2002000082A (fr)
TN (1) TNSN00113A1 (fr)
TR (1) TR200103391T2 (fr)
WO (1) WO2000073298A1 (fr)
ZA (1) ZA200109691B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
GB0027410D0 (en) * 2000-11-09 2000-12-27 Pfizer Ltd Mutual prodrug of amlodipine and atorvastatin
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
MXPA03011566A (es) 2001-06-11 2004-10-28 Xenoport Inc Formas de dosificacion de profarmacos de analogos de gaba administrados oralmente que tienen toxicidad reducida.
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
DE10140421A1 (de) * 2001-08-17 2003-03-06 Bayer Ag Neue Kombination
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US7071210B2 (en) * 2002-07-02 2006-07-04 Pfizer Inc. CETP inhibitors in combination with antihypertensive agents and uses thereof
US20040053842A1 (en) * 2002-07-02 2004-03-18 Pfizer Inc. Methods of treatment with CETP inhibitors and antihypertensive agents
EP1811986B1 (fr) 2004-11-04 2014-03-26 XenoPort, Inc. Formes posologiques orales a liberation prolongee d'un promedicament de la gabapentine
WO2007016306A2 (fr) * 2005-08-01 2007-02-08 Psivida Inc. Composes inhibiteurs de l'enzyme de conversion de l'angiotensine- inhibiteurs de la hmgcoa reductase
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8354116B2 (en) * 2007-06-18 2013-01-15 Biochemics, Inc. Bifunctional synthetic molecules
WO2009047964A1 (fr) 2007-10-10 2009-04-16 Nok Corporation Accumulateur

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US4681893A (en) 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.

Also Published As

Publication number Publication date
ES2220426T3 (es) 2004-12-16
AU3313900A (en) 2000-12-18
NO20015756D0 (no) 2001-11-26
WO2000073298A1 (fr) 2000-12-07
ATE268764T1 (de) 2004-06-15
PT1180102E (pt) 2004-08-31
HK1046282A1 (zh) 2003-01-03
DE60011424T2 (de) 2005-08-25
CZ20014229A3 (cs) 2003-01-15
CA2375372A1 (fr) 2000-12-07
TR200103391T2 (tr) 2002-04-22
JP2003500487A (ja) 2003-01-07
CO5170457A1 (es) 2002-06-27
DZ3048A1 (fr) 2004-03-27
EA200101130A1 (ru) 2002-04-25
BG106149A (bg) 2002-05-31
PE20010169A1 (es) 2001-02-10
NO20015756L (no) 2002-01-24
ZA200109691B (en) 2002-11-26
HN2000000075A (es) 2001-02-02
HRP20010856A2 (en) 2002-12-31
AR022344A1 (es) 2002-09-04
EP1180102A1 (fr) 2002-02-20
PA8495701A1 (es) 2001-12-14
MXPA01012125A (es) 2002-06-04
KR20020012247A (ko) 2002-02-15
PL353483A1 (en) 2003-11-17
EE200100631A (et) 2003-02-17
SV2002000082A (es) 2002-02-05
US6486182B1 (en) 2002-11-26
CN1352640A (zh) 2002-06-05
TNSN00113A1 (fr) 2005-11-10
AP2001002345A0 (en) 2001-12-31
IS6135A (is) 2001-10-30
HUP0201433A2 (en) 2002-08-28
CA2375372C (fr) 2007-01-09
DK1180102T3 (da) 2004-09-06
IL145947A0 (en) 2002-07-25
DE60011424D1 (de) 2004-07-15
OA11950A (en) 2006-04-13
EP1180102B9 (fr) 2005-03-02
BR0011006A (pt) 2002-02-19
SK16792001A3 (sk) 2003-03-04
EP1180102B1 (fr) 2004-06-09
GT200000078A (es) 2001-11-16

Similar Documents

Publication Publication Date Title
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26622A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26630A1 (fr) 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26730A1 (fr) Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26571A1 (fr) Derives d'acide hydroxamique, compositions pharmaceutiques les contenant et procede pour leur preparation
DZ2890A1 (fr) 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26620A1 (fr) Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26536A1 (fr) Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation.
FR2740136B1 (fr) Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26680A1 (fr) Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26439A1 (fr) Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26653A1 (fr) Pyrrolo [2,3- d] pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2523A1 (fr) Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation.
PL355844A1 (en) Novel pharmaceutical compositions of anti-tubrcular drugs and process for their preparation
MA26614A1 (fr) Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2729951B1 (fr) Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
MA26669A1 (fr) 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26465A1 (fr) Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26740A1 (fr) Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26611A1 (fr) Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2550A1 (fr) Dérivés d'azétidinylpropylpipéridine procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3048A1 (fr) Précurseurs médicamenteux mutuels d'amlopidine et d'atorvastine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26417A1 (fr) Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant
MA26501A1 (fr) Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant